Sue Katz is the Senior Director of Clinical Operations at Johnson & Johnsons pharmaceutical division, Janssen. With over 20 years of experience, she leads global clinical trial execution for the immunology portfolio and is a University of Delaware alumna focused on innovative research solutions.
She is a prominent advocate for integrating patient-centric approaches into the clinical trial process, frequently speaking on the topic at industry events.
Sue Katz
Sr. Director, Clinical Operations at Johnson & Johnson Pharamceutical Research and Development (JJPRD)
Titusville, New Jersey, United States
Overview
Topics They Care About
Clinical Trial Execution
Leads global teams responsible for the end-to-end execution of clinical trials, ensuring operational excellence for Johnson & Johnson's immunology portfolio.
Patient Centricity
A key focus of her work and public speaking, she champions making clinical trials more focused on the patient's experience and needs.
Immunology Portfolio
Her specific area of therapeutic focus where she oversees all clinical operations for Janssen's research and development in this field.
Media Appearances
Sue has no verified media appearances
Work History
Sr. Director, Clinical Operations at Johnson & Johnson Pharamceutical Research and Development (JJPRD)
Education
1978 - 1981
Education details unavailable from University of Delaware
More Information
Social Presence :
Prographics :
Exp : N/A
Location : Titusville, New Jersey, United States
Job Level : Senior
Designation : Sr. Director, Clinical Operations at Johnson & Johnson Pharamceutical Research and Development (JJPRD)
